A Tale of Two Diets and Diabetes

Both a low-glycemic-index diet-one rich in foods that release glucose in the blood slowly-and a high-cereal-fiber diet have shown benefits for people with diabetes. But the low-glycemic-index was more effective in a recent study at helping people control their blood glucose. Here's a look at how the study worked and how the diets differed.

In the study, 210 people with type 2 diabetes were put into either a high-cereal-fiber group or a group whose diet... read more

Submitted by rbergman

• 142 Views
• 0 Comments

Does Diabetes Have a Genetic Link?

How did I get diabetes? Why did I get it? If I have diabetes, what are the chances that my children will get it, too?

If you've been recently diagnosed with diabetes, these questions are probably cascading through your mind, and the fear of the unknown might be setting in. Rest assured that research into genetic and environmental risk factors is ongoing, and new answers are being discovered all the time.

Submitted by rbergman

• 72 Views
• 0 Comments

Low-Carb Diets & Memory Loss

Low-Carb Diets and Memory Loss: Is There a Link?

You may be losing more than just a quick pound.

By Seth Czarnecki,
QualityHealth News

Few would argue the fact that low-carb diets work in the short run, but what these dieters might not realize are the effects that a lack of carbohydrates may have on other parts of the body. A study of both low-carb and low-calorie dieters conducted at Tufts University in Massachusetts... read more

Submitted by rbergman

• 122 Views
• 2 Comments

The Glucose-Monitoring Tattoo: A novel nanosensor could be used for skin-based glucose sensing.

Scientists at Draper Laboratory, in Cambridge, MA, are developing a nanosensor that could be injected into the skin, much like tattoo dye, to monitor an individual's blood-sugar level. Wow!

Submitted by Amy Tenderich

• 162 Views
• 3 Comments

Higher A1C Levels Linked to Lower Brain Function

This is very bad news indeed. More reason to maintain good glucose control!

Submitted by Amy Tenderich

• 139 Views
• 3 Comments

America Losing the Fight With Type 2 Diabetes

TUESDAY, Dec. 30 -- The type 2 diabetes epidemic that continues to sweep across the United States has left an estimated 24 million Americans struggling with the disease, up more than 3 million people since 2005.

And, of course, with the epidemic comes the wave of illnesses and disabilities brought on by diabetes -- heart disease and stroke, blindness, amputations, kidney disease and nervous system damage.

Doctors are trying to reverse the tide... read more

Submitted by Gabby

• 111 Views
• 1 Comment

UPDATE 1-Takeda: US FDA to respond on diabetes drug by June

TOKYO, Dec 24 (Reuters) - Takeda Pharmaceutical Co Ltd (4502.T), Japan's top drugmaker, said on Wednesday the U.S. Food and Drug Administration would complete a review of a key diabetes drug candidate by June 26, 2009.

The drug, called alogliptin or SYR-322, is critical to Takeda's mainstay diabetes business as it is expected to be the main replacement for its best-selling Actos, which will lose U.S. patent protection in 2011.

In October, Takeda said the... read more

Submitted by Avera

• 87 Views
• 2 Comments

Biocompatibles in $422M Deal With AstraZeneca in Diabetes

Biocompatibles International plc sealed a deal with AstraZeneca plc worth a potential €302.3 million (US$422.6 million) for a glucagon-like peptide (GLP-1) analogue for treating diabetes and obesity.

As yet, the compound is in discovery. Signing the agreement triggers payment of €8.8 million to complete preclinical development and take the product through to Phase IIa. "At that point AstraZeneca will decide whether or not to take up the option to license [the product], in which... read more

Submitted by Avera

• 112 Views
• 0 Comments

Managing Diabetes Over Holidays

Some good tips for "keeping it together" over the holidays.

Submitted by Amy Tenderich

• 103 Views
• 2 Comments

"Hundreds Dead" in Failed Diabetes Drug Trial

The National Institutes of Health's (NIH) National Heart, Lung and Blood Institute has announced the early cancellation of one part of a major diabetes and cardiovascular disease study after discovering that patients undergoing that treatment were more likely to die from heart attacks and strokes.

The Action to Control Cardiovascular Risk in Diabetes (ACCORD) study included 10,251 adults with Type 2 diabetes who were considered to be at especially high risk of heart attacks and... read more

Submitted by Avera

• 132 Views
• 1 Comment